TE_171
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MSTC |
|---|---|
| TE superfamily | MaLR |
| TE class | LTR |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 1.99 |
| Counts of samples | TCGA_tumor:135; TCGA_normal:4; GTEx:72 |
| TSS | chr1(-):17140154 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_171.1 | - | Intergenic | Non-coding | Non-coding | chr1(-):17134693,17134713,17134773,17136628,17140023,17140155 |
| teRNA_171.2 | - | Intergenic | Non-coding | Non-coding | chr1(-):17134737,17134757,17134846,17136628,17140023,17140155 |
| teRNA_171.3 | - | Intergenic | Non-coding | Non-coding | chr1(-):17135021,17135041,17135207,17136628,17140023,17140155 |
| teRNA_171.4 | - | Intergenic | Non-coding | Non-coding | chr1(-):17134480,17134500,17136576,17136628,17140023,17140155 |
| teRNA_171.5 | - | Intergenic | Non-coding | Non-coding | chr1(-):17135021,17135041,17135117,17136628,17140023,17140155 |
| teRNA_171.6 | - | Intergenic | Non-coding | Non-coding | chr1(-):17126382,17126402,17136576,17136628,17140023,17140155 |
| teRNA_171.7 | - | Intergenic | Non-coding | Non-coding | chr1(-):17134752,17134772,17134858,17136628,17140023,17140155 |
| teRNA_171.8 | - | Intergenic | Non-coding | Non-coding | chr1(-):17134681,17134701,17134795,17136628,17140023,17140155 |
| teRNA_171.9 | - | Intergenic | Non-coding | Non-coding | chr1(-):17134645,17134665,17134773,17136628,17140023,17140155 |
| teRNA_171.10 | - | Intergenic | Non-coding | Non-coding | chr1(-):17135021,17135041,17135076,17136628,17140023,17140155 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
